Abstract
The mechanistic target of rapamycin (mTOR), a protein kinase, is a central regulator of mammalian metabolism and physiology. Protein mTOR complex 1 (mTORC1) functions as a major sensor for the nutrient, energy, and redox state of a cell and is activated by ras homolog enriched in brain (RHEB1), a GTP-binding protein. Increased activation of mTORC1 pathway has been associated with developmental abnormalities, certain form of epilepsy (tuberous sclerosis), and cancer. Clinically, those mTOR-related disorders are treated with the mTOR inhibitor rapamycin and its rapalogs. Because the effects of chronic interference with mTOR signaling in the aged brain are yet unknown, we used a genetic strategy to interfere with mTORC1 signaling selectively by introducing mutations of Rheb1 into the mouse. We created conventional knockout (Rheb1 +/−) and gene trap (Rheb1 Δ/+) mutant mouse lines. Rheb1-insufficient mice with different combinations of mutant alleles were monitored over a time span of 2 years. The mice did not show any behavioral/neurological changes during the first 18 months of age. However, after aging (> 18 months of age), both the Rheb1 +/− and Rheb1 Δ /− hybrid males developed rare stress-induced seizures, whereas Rheb1 +/− and Rheb1 Δ /− females and Rheb1 Δ/+ and Rheb1 Δ/Δ mice of both genders did not show any abnormality. Our findings suggest that chronic intervention with mTORC1 signaling in the aged brain might be associated with major adverse events.
Similar content being viewed by others
References
Abs E, Goorden SM, Schreiber J, Overwater IE, Hoogeveen-Westerveld M, Bruinsma CF, Aganovic E, Borgesius NZ, Nellist M, Elgersma Y (2013) TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice. Ann Neurol 74(4):569–579. https://doi.org/10.1002/ana.23943
Aspuria PJ, Tamanoi F (2004) The Rheb family of GTP-binding proteins. Cell Signal 16(10):1105–1112. https://doi.org/10.1016/j.cellsig.2004.03.019
Bilbey DL, Salem H, Grossman MH (1960) The anatomical basis of the straub phenomenon. Br J Pharmacol Chemother 15(4):540–543
Blagosklonny MV (2010) Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle 9(16):3151–3156. https://doi.org/10.4161/cc.9.16.13120
Blair J, Barry R, Moore DJ, Denniston AK (2017) A comprehensive review of mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis. Curr Pharm Des 23(20):3005-3014. doi:https://doi.org/10.2174/1381612823666170111125550
Brodie MJ, Elder AT, Kwan P (2009) Epilepsy in later life. Lancet Neurol 8(11):1019–1030. https://doi.org/10.1016/S1474-4422(09)70240-6
Caban C, Khan N, Hasbani DM, Crino PB (2017) Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet 10:1–8. https://doi.org/10.2147/TACG.S90262
Calimeri T, Ferreri AJ (2017) m-TOR inhibitors and their potential role in haematological malignancies. Br J Haematol. https://doi.org/10.1111/bjh.14529
Clutton-Brock TH, Isvaran K (2007) Sex differences in ageing in natural populations of vertebrates. Proc Biol Sci 274(1629):3097–3104. https://doi.org/10.1098/rspb.2007.1138
Donati M, Paolino G, Muscardin L, Panetta C, Donati P (2017) Resolution of benign and malignant sebaceous neoplasms, in a renal transplant patient treated with Everolimus. Exp Clin Transplant 15(1):100–102. https://doi.org/10.6002/ect.2014.0208
Duarte-Guterman P, Yagi S, Chow C, Galea LA (2015) Hippocampal learning, memory, and neurogenesis: effects of sex and estrogens across the lifespan in adults. Horm Behav 74:37–52. https://doi.org/10.1016/j.yhbeh.2015.05.024
Fedorov LM, Haegel-Kronenberger H, Hirchenhain J (1997) A comparison of the germline potential of differently aged ES cell lines and their transfected descendants. Transgenic Res 6(3):223–231
Fedorov LM, Schmittwolf C, Amann K, Thomas WH, Muller AM, Schubert H, Domen J, Kneitz B (2006) Renal failure causes early death of bcl-2 deficient mice. Mech Ageing Dev 127(7):600–609. https://doi.org/10.1016/j.mad.2006.02.009
Franz DN (2011) Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis. Expert Rev Anticancer Ther 11(8):1181–1192. https://doi.org/10.1586/era.11.93
Franz DN, Belousova E, Sparagana S, Bebin EM, Frost MD, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Berkowitz N, Niolat J, Jozwiak S (2016) Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study. PLoS One 11(6):e0158476. https://doi.org/10.1371/journal.pone.0158476
French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Berkowitz N, Voi M, Peyrard S, Pelov D, Franz DN (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388(10056):2153–2163. https://doi.org/10.1016/S0140-6736(16)31419-2
Furian L, Silvestre C, Vallese L, Baldan N, Donato P, Bonfante L, Cavallin F, Marchini F, Rigotti P (2014) Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors. Transplant Proc 46(10):3390–3395. https://doi.org/10.1016/j.transproceed.2014.08.044
Goorden SM, van Woerden GM, van der Weerd L, Cheadle JP, Elgersma Y (2007) Cognitive deficits in Tsc1+/− mice in the absence of cerebral lesions and seizures. Ann Neurol 62(6):648–655. https://doi.org/10.1002/ana.21317
Goorden SM, Hoogeveen-Westerveld M, Cheng C, van Woerden GM, Mozaffari M, Post L, Duckers HJ, Nellist M, Elgersma Y (2011) Rheb is essential for murine development. Mol Cell Biol 31(8):1672–1678. https://doi.org/10.1128/MCB.00985-10
Goorden SM, Abs E, Bruinsma CF, Riemslagh FW, van Woerden GM, Elgersma Y (2015) Intact neuronal function in Rheb1 mutant mice: implications for TORC1-based treatments. Hum Mol Genet 24(12):3390–3398. https://doi.org/10.1093/hmg/ddv087
Gowaty PA (2007) Sex differences in ageing in natural populations of mammals and birds. J Biosci 32(7):1221–1222
Gromov PS, Madsen P, Tomerup N, Celis JE (1995) A novel approach for expression cloning of small GTPases: identification, tissue distribution and chromosome mapping of the human homolog of rheb. FEBS Lett 377(2):221–226
Hanker AB, Mitin N, Wilder RS, Henske EP, Tamanoi F, Cox AD, Der CJ (2010) Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling. Oncogene 29(3):380–391. https://doi.org/10.1038/onc.2009.336
Harai T, Inoue R, Fujita Y, Tanaka A, Horio M, Hashimoto K, Hongou K, Miyawaki T, Mori H (2012) Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice. Epilepsy Res 102(3):180–187. https://doi.org/10.1016/j.eplepsyres.2012.06.001
Heard JJ, Fong V, Bathaie SZ, Tamanoi F (2014) Recent progress in the study of the Rheb family GTPases. Cell Signal 26(9):1950–1957. https://doi.org/10.1016/j.cellsig.2014.05.011
Jeong A, Wong M (2016) mTOR inhibitors in children: current indications and future directions in neurology. Curr Neurol Neurosci Rep 16(12):102. https://doi.org/10.1007/s11910-016-0708-8
Kaufmann MH (2003) The Atlas of Mouse Development. Elsevier Academic Press, London
Krueger DA, Care MM, Holland K, Agricola K, Tudor C, Mangeshkar P, Wilson KA, Byars A, Sahmoud T, Franz DN (2010) Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363(19):1801–1811. https://doi.org/10.1056/NEJMoa1001671
Krueger DA, Wilfong AA, Mays M, Talley CM, Agricola K, Tudor C, Capal J, Holland-Bouley K, Franz DN (2016) Long-term treatment of epilepsy with everolimus in tuberous sclerosis. Neurology 87(23):2408–2415. https://doi.org/10.1212/WNL.0000000000003400
Lee JH, Tecedor L, Chen YH, Monteys AM, Sowada MJ, Thompson LM, Davidson BL (2015) Reinstating aberrant mTORC1 activity in Huntington’s disease mice improves disease phenotypes. Neuron 85(2):303–315. https://doi.org/10.1016/j.neuron.2014.12.019
Li Y, Inoki K, Guan KL (2004) Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol Cell Biol 24(18):7965–7975. https://doi.org/10.1128/MCB.24.18.7965-7975.2004
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262
Maas DA, Vallès A, Martens GJM (2017) Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia. Transl Psychiatry 7:e1171. https://doi.org/10.1038/tp.2017.138 published online 18 July 2017
Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA (2006) RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci Off J Soc Neurosci 26(39):9996–10005. https://doi.org/10.1523/JNEUROSCI.3292-06.2006
Manning BD, Cantley LC (2003) Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 28(11):573–576. https://doi.org/10.1016/j.tibs.2003.09.003
Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, Jensen FE, Kwiatkowski DJ (2007) A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci Off J Soc Neurosci 27(21):5546–5558. https://doi.org/10.1523/JNEUROSCI.5540-06.2007
Mendus D, Rankin-Gee EK, Mustapha M, Porter BE (2015) Increased sensitivity to kindling in mice lacking TSP1. Neuroscience 305:302–308. https://doi.org/10.1016/j.neuroscience.2015.07.075
Mizuguchi M, Takashima S (2001) Neuropathology of tuberous sclerosis. Brain Dev 23(7):508–515
Mizuki N, Kimura M, Ohno S, Miyata S, Sato M, Ando H, Ishihara M, Goto K, Watanabe S, Yamazaki M, Ono A, Taguchi S, Okumura K, Nogami M, Taguchi T, Ando A, Inoko H (1996) Isolation of cDNA and genomic clones of a human Ras-related GTP-binding protein gene and its chromosomal localization to the long arm of chromosome 7, 7q36. Genomics 34(1):114–118
Paccalin M, Pain-Barc S, Pluchon C, Paul C, Besson MN, Carret-Rebillat AS, Rioux-Bilan A, Gil R, Hugon J (2006) Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord 22(4):320–326. https://doi.org/10.1159/000095562
Panksepp JB, Jochman KA, Kim JU, Koy JJ, Wilson ED, Chen Q, Wilson CR, Lahvis GP (2007) Affiliative behavior, ultrasonic communication and social reward are influenced by genetic variation in adolescent mice. PLoS One 2(4):e351. https://doi.org/10.1371/journal.pone.0000351
Pelletier C, Majethia U, Forsythe A (2016) Comparative effectiveness research in renal cell carcinoma: Lenvatinib with everolimus as a potential new treatment option. J Clin Oncol 34(7_suppl):27. https://doi.org/10.1200/jco.2016.34.7_suppl.27
Racine RJ (1972) Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol 32(3):269–279
Sanchis-Segura C, Becker JB (2016) Why we should consider sex (and study sex differences) in addiction research. Addict Biol 21(5):995–1006. https://doi.org/10.1111/adb.12382
Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98(3):503–517
Tamai T, Yamaguchi O, Hikoso S, Takeda T, Taneike M, Oka T, Oyabu J, Murakawa T, Nakayama H, Uno Y, Horie K, Nishida K, Sonenberg N, Shah AM, Takeda J, Komuro I, Otsu K (2013) Rheb (Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1 (mTORC1) activation becomes indispensable for cardiac hypertrophic growth after early postnatal period. J Biol Chem 288(14):10176–10187. https://doi.org/10.1074/jbc.M112.423640
Tee AR, Anjum R, Blenis J (2003a) Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. J Biol Chem 278(39):37288–37296. https://doi.org/10.1074/jbc.M303257200
Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J (2003b) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13(15):1259–1268
Terauchi A, Johnson-Venkatesh EM, Toth AB, Javed D, Sutton MA, Umemori H (2010) Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 465(7299):783–787. https://doi.org/10.1038/nature09041
Tian Q, Hanlon Newell AE, Wang Y, Olson SB, Fedorov LM (2011) Complex cytogenetic analysis of early lethality mouse embryos. Chromosom Res 19(4):567–574. https://doi.org/10.1007/s10577-011-9209-4
Tian Q, Smart JL, Clement JH, Wang Y, Derkatch A, Schubert H, Danilchik MV, Marks DL, Fedorov LM (2016) RHEB1 expression in embryonic and postnatal mouse. Histochem Cell Biol 145(5):561–572. https://doi.org/10.1007/s00418-015-1394-3
Uhlmann EJ, Wong M, Baldwin RL, Bajenaru ML, Onda H, Kwiatkowski DJ, Yamada K, Gutmann DH (2002) Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol 52(3):285–296. https://doi.org/10.1002/ana.10283
Uhlmann EJ, Li W, Scheidenhelm DK, Gau CL, Tamanoi F, Gutmann DH (2004) Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation. Glia 47(2):180–188. https://doi.org/10.1002/glia.20036
Urano J, Tabancay AP, Yang W, Tamanoi F (2000) The Saccharomyces cerevisiae Rheb G-protein is involved in regulating canavanine resistance and arginine uptake. J Biol Chem 275(15):11198–11206
Voss AK, Thomas T, Gruss P (1998) Compensation for a gene trap mutation in the murine microtubule-associated protein 4 locus by alternative polyadenylation and alternative splicing. Dev Dyn 212(2):258–266. https://doi.org/10.1002/(SICI)1097-0177(199806)212:2<258::AID-AJA10>3.0.CO;2-0
Wei KC, Lai PC (2015) Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis. Dermatol Ther 28(1):25–27. https://doi.org/10.1111/dth.12176
Wiebe MS, Nichols RJ, Molitor TP, Lindgren JK, Traktman P (2010) Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia. Biol Reprod 82(1):182–193. https://doi.org/10.1095/biolreprod.109.079095
Yamagata K, Sanders LK, Kaufmann WE, Yee W, Barnes CA, Nathans D, Worley PF (1994) Rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J Biol Chem 269(23):16333–16339
Yashin AI, Wu D, Arbeev KG, Ukraintseva SV (2010) Joint influence of small-effect genetic variants on human longevity. Aging (Albany NY) 2(9):612–620. 10.18632/aging.100191
Zeng LH, Xu L, Gutmann DH, Wong M (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63(4):444–453. https://doi.org/10.1002/ana.21331
Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M (2011) Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet 20(3):445–454. https://doi.org/10.1093/hmg/ddq491
Zou J, Zhou L, Du XX, Ji Y, Xu J, Tian J, Jiang W, Zou Y, Yu S, Gan L, Luo M, Yang Q, Cui Y, Yang W, Xia X, Chen M, Zhao X, Shen Y, Chen PY, Worley PF, Xiao B (2011) Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev Cell 20(1):97–108. https://doi.org/10.1016/j.devcel.2010.11.020
Acknowledgements
We are saddened to report that, during the writing of this manuscript, our colleague and co-author Dr. Falk Weih passed away. We gratefully acknowledge Alex Derkatch, Galina Fedorova, and James Smart for the expert technical assistance. We also thank Harald Schubert for providing the laboratory space and T. Gridley for the CJ7 ES cells. We acknowledge the DNA core facility at OHSU for the sequencing analysis. We acknowledge Garet Lahvis and Stephanie Krasnow for their excellent advices. John Crabbe and Pamela Metten are thanked for the helpful discussions and comments on the manuscript. The work was partly supported by Medical Research Foundation (Portland, Oregon), grant no. 9003823, the Office of the Vice President for Research at OHSU, and an NBL-3 grant from Bundesministerium für Bildung und Forschung, Germany.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
Falk Weih deceased
Electronic supplementary material
Supplemental Table 1
(DOCX 13 kb)
About this article
Cite this article
Tian, Q., Gromov, P., Clement, J.H. et al. RHEB1 insufficiency in aged male mice is associated with stress-induced seizures. GeroScience 39, 557–570 (2017). https://doi.org/10.1007/s11357-017-9997-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-017-9997-3